FamiCord Group Nakiller

Filter by:

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 cord blood talassemia major hematology 2018 standard therapy Turkey 9,5
2 autologous cord blood aplastic anaemia hematology 2018 standard therapy Poland 3,5
3 cord blood chronic granulomatous disease hematology 2017 standard therapy Turkey 3,9
4 autologous cord blood autism neurology 2017 experimental therapy Poland 4,1
5 autologous cord blood autism neurology 2017 experimental therapy Poland 4,1
6 autologous cord blood autism neurology 2017 experimental therapy Poland 5,4
7 autologous cord blood autism neurology 2017 experimental therapy Poland 7,3
8 autologous cord blood autism neurology 2017 experimental therapy Poland 6,2
9 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 6,8
10 cord blood relapse of acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7,3
11 autologous cord blood autism neurology 2017 experimental therapy Poland 4,11
12 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 10,3
13 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 5,4
14 autologous cord blood cerebral palsy neurology 2017 experimental therapy Poland 2,2
15 cord blood talassemia major hematology 2017 standard therapy Turkey 4,1
16 cord blood talassemia major hematology 2017 standard therapy Turkey 4,0
17 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 9,6
18 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
19 autologous cord blood autism neurology 2016 experimental therapy Poland 6
20 cord blood + peripheral blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
21 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
22 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
23 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10/12
24 cord blood beta-talassemia, agranulocytosis hematology 2013 standard therapy Turkey 8
25 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
26 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
27 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
28 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3,5
29 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
30 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
31 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7,5
32 cord blood histiocytosis hematology 2011 standard therapy Poland 2,5
33 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
34 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
35 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
36 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1,5
37 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
38 autologous cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1,5
39 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
40 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
41 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2018 experimental therapy Poland no data
42 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 66,2
43 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 47,1
44 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 64,4
45 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 10,9
46 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2018 experimental therapy Poland 1,9
47 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 9,5
48 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 70,11
49 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 40,9
50 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 31,2
51 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 60,2
52 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 65,2
53 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 65,7
54 cord tissue (Wharton's jelly) muscular dystrophy neurology 2018 experimental therapy Poland 22,6
55 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2018 experimental therapy Poland 8,8
56 cord tissue (Wharton's jelly) holoprosencephalia neurology 2018 experimental therapy Poland 12,2
57 cord tissue (Wharton's jelly) spinal cord injury neurology 2018 experimental therapy Poland 25,9
58 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 80,5
59 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 35,1
60 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 54,4
61 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 76,1
62 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 9,4
63 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 2,4
64 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 80,3
65 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2018 experimental therapy Poland 27,4
66 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 4,11
67 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 75,5
68 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2018 experimental therapy Poland 34,1
69 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 20,8
70 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 61,3
71 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 28,6
72 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 45,11
73 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 57,5
74 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 57,8
75 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 83,5
76 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 35
77 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 41,9
78 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 67,11
79 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2018 experimental therapy Poland 7,0
80 cord tissue (Wharton's jelly) damage to the intercondylar fissure of the right knee orthopedics 2018 experimental therapy Poland 40,2
81 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 54,2
82 cord tissue (Wharton's jelly) encephalopathy neurology 2018 experimental therapy Poland 54,8
83 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 6,10
84 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 8,3
85 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 2,11
86 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 9,0
87 cord tissue (Wharton's jelly) developmental delay neurology 2018 experimental therapy Poland 7,11
88 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 40,0
89 cord tissue (Wharton's jelly) muscular dystrophy neurology 2018 experimental therapy Poland 21,7
90 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 62,5
91 cord tissue (Wharton's jelly) autism neurology 2018 experimental therapy Poland 8,5
92 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 3,8
93 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 28,6
94 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 52,11
95 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 47,3
96 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2018 experimental therapy Poland 46,1
97 cord tissue (Wharton's jelly) Friedreich's ataxia neurology 2018 experimental therapy Poland 31,5
98 cord tissue (Wharton's jelly) Friedreich's ataxia neurology 2018 experimental therapy Poland 27,6
99 cord tissue (Wharton's jelly) stroke neurology 2018 experimental therapy Poland 70,1
100 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 9,2
101 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 55,8
102 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2018 experimental therapy Poland 20,6
103 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 34,2
104 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 44,2
105 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 30,4
106 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2018 experimental therapy Poland 46,7
107 cord tissue (Wharton's jelly) epilepsia neurology 2018 experimental therapy Poland 20,9
108 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 65,2
109 cord tissue (Wharton's jelly) spinal cord injury neurology 2018 experimental therapy Poland 30,9
110 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 38,1
111 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 46,2
112 cord tissue (Wharton's jelly) developmental delay neurology 2018 experimental therapy Poland 14
113 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 38,6
114 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 51,9
115 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 50,8
116 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 59,3
117 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 47,8
118 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 66,3
119 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 52,3
120 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2018 experimental therapy Poland 33,11
121 cord tissue (Wharton's jelly) spina bifida neurology 2018 experimental therapy Poland 3,1
122 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 27,2
123 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 34,11
124 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 36,6
125 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 55,4
126 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 39,5
127 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 46,7
128 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 32,3
129 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 41,8
130 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2018 experimental therapy Poland 34,7
131 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2018 experimental therapy Poland 1,11
132 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 67,10
133 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 66,8
134 cord tissue (Wharton's jelly) muscular dystrophy neurology 2018 experimental therapy Poland 28,1
135 cord tissue (Wharton's jelly) myopathy neurology 2018 experimental therapy Poland 57,3
136 cord tissue (Wharton's jelly) spina bifida neurology 2018 experimental therapy Poland 2,6
137 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 52,8
138 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 44,3
139 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 48,11
140 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2018 experimental therapy Poland 59,10
141 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2018 experimental therapy Poland 3,7
142 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2018 experimental therapy Poland 44,11
143 cord tissue (Wharton's jelly) cerebral palsy neurology 2018 experimental therapy Poland 16,7
144 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2018 experimental therapy Poland 61,11
145 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 36,3
146 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2018 experimental therapy Poland 25,5
147 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 31,11
148 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2018 experimental therapy Poland 68,5
149 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,8
150 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 57,1
151 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2017 experimental therapy Poland 67,7
152 cord tissue (Wharton's jelly) moyamoya disease neurology 2017 experimental therapy Poland 17,7
153 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 9/12
154 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 7,11
155 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
156 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,5
157 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,2
158 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 14,4
159 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 15,9
160 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 8,3
161 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,8
162 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,10
163 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 7,6
164 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,6
165 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,8
166 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
167 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,3
168 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,9
169 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2017 experimental therapy Poland 33,0
170 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 7,4
171 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,6
172 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2017 experimental therapy Poland 2,4
173 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,2
174 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,5
175 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,8
176 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 46,5
177 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 59,0
178 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,10
179 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,1
180 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 46,10
181 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 64,3
182 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 69,2
183 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 5,10
184 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
185 cord tissue (Wharton's jelly) autism, encephalopathy neurology 2017 experimental therapy Poland 7,11
186 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2017 experimental therapy Poland 2,1
187 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 52,8
188 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,6
189 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 17,0
190 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 10,9
191 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,10
192 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,7
193 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,5
194 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 29,8
195 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
196 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,8
197 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 10,3
198 cord tissue (Wharton's jelly) congenital malformations of the nervous system, unspecified neurology 2017 experimental therapy Poland 8,2
199 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,11
200 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 35,9
201 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 52,6
202 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 8,0
203 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,6
204 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 28,7
205 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
206 cord tissue (Wharton's jelly) other specific disorders of the central nervous system neurology 2017 experimental therapy Poland 2,1
207 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 85,7
208 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 66,8
209 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 12,2
210 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,1
211 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 14,5
212 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 38,4
213 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 24,8
214 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 11,10
215 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,2
216 cord tissue (Wharton's jelly) spinal cord injury, tetraparesis orthopedics 2017 experimental therapy Poland 42,9
217 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,10
218 cord tissue (Wharton's jelly) tetraparesis spastica, epilepsia neurology 2017 experimental therapy Poland 2,8
219 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,10
220 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 65,6
221 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,3
222 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 12,11
223 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 3,4
224 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,8
225 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,7
226 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 44,0
227 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 22,10
228 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 1,11
229 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,6
230 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 32,9
231 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 1,6
232 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 10,0
233 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,2
234 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,8
235 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 18,5
236 cord tissue (Wharton's jelly) delayed psychomotor development, epilepsia neurology 2017 experimental therapy Poland 11,8
237 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 9,10
238 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 22,4
239 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,11
240 cord tissue (Wharton's jelly) condition after myelitis neurology 2017 experimental therapy Poland 34,11
241 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 33,8
242 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 78,6
243 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,6
244 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 77,5
245 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,6
246 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,3
247 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,4
248 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,6
249 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,9
250 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,0
251 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 27,3
252 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,2
253 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,3
254 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
255 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
256 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 53,10
257 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 55,2
258 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,4
259 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
260 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2017 experimental therapy Poland 3,6
261 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,3
262 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
263 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 9,11
264 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 8,10
265 cord tissue (Wharton's jelly) tetraparesis orthopedics 2017 experimental therapy Poland 27,11
266 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland b/d
267 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 16,4
268 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 35,5
269 cord tissue (Wharton's jelly) leukodystrophy neurology 2017 experimental therapy Poland 7,1
270 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 53,9
271 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,5
272 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,11
273 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 57,9
274 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 62,9
275 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,0
276 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
277 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,7
278 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,2
279 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 58,7
280 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 25,2
281 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 38,0
282 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
283 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 10,8
284 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,11
285 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,8
286 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 7,11
287 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 60,1
288 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 49,1
289 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,3
290 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 68,1
291 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,7
292 cord tissue (Wharton's jelly) myopathy of congenital fiber type disproportion, damage to the central nervous system neurology 2017 experimental therapy Poland 2,2
293 cord tissue (Wharton's jelly) epilepsia, autism neurology 2017 experimental therapy Poland 6,0
294 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,3
295 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,10
296 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 31,3
297 cord tissue (Wharton's jelly) Devic’s disease neurology 2017 experimental therapy Poland 45,2
298 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,4
299 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,1
300 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,5
301 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
302 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,5
303 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,9
304 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,1
305 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,8
306 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,4
307 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 26,9
308 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 12,10
309 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
310 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,8
311 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,1
312 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,4
313 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,5
314 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 65,1
315 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 70,11
316 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
317 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,7
318 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 74,5
319 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 43,8
320 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
321 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2017 experimental therapy Poland 23,9
322 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 76,10
323 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,2
324 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 3,2
325 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 3,5
326 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 7,9
327 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,11
328 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,4
329 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,2
330 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
331 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,7
332 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 30,11
333 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 2,4
334 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 42,1
335 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33,4
336 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,6
337 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 4,1
338 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 56,4
339 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 4,7
340 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 41,11
341 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,10
342 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 46,9
343 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32,3
344 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 6,7
345 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
346 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,0
347 cord tissue (Wharton's jelly) encephalopathy, cerebral palsy neurology 2017 experimental therapy Poland 1,5
348 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,8
349 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,10
350 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 35,4
351 cord tissue (Wharton's jelly) condition after encephalitis neurology 2017 experimental therapy Poland 19,7
352 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,1
353 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,0
354 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,3
355 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,4
356 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
357 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,1
358 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,5
359 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 62,5
360 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 48,10
361 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 31,5
362 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45,5
363 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
364 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
365 cord tissue (Wharton's jelly) Krabbe disease neurology 2017 experimental therapy Poland 6,3
366 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,9
367 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 5,0
368 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
369 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
370 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 12,5
371 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,7
372 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33,5
373 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,2
374 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 31,9
375 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,9
376 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,6
377 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63,11
378 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,11
379 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 77,2
380 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
381 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,1
382 cord tissue (Wharton's jelly) ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37,11
383 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,11
384 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 11,10
385 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 13,0
386 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 52,0
387 cord tissue (Wharton's jelly) syndrom IFAP hematology 2017 experimental therapy Poland 3,5
388 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 6,3
389 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 3,5
390 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
391 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,3
392 cord tissue (Wharton's jelly) hydrocephalus, neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2,3
393 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 31,6
394 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 34,10
395 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 45,4
396 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 27,11
397 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,11
398 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,1
399 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,7
400 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 24,9
401 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 69,10
402 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 17,11
403 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 14,1
404 cord tissue (Wharton's jelly) traumatic brain injury neurology 2017 experimental therapy Poland 9,4
405 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,4
406 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 6,4
407 cord tissue (Wharton's jelly) cerebral palsy, epilepsy neurology 2017 experimental therapy Poland 5,8
408 cord tissue (Wharton's jelly) encephalopathy, cerebral palsy neurology 2017 experimental therapy Poland 4,4
409 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1,7
410 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 37,11
411 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,11
412 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,1
413 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40,11
414 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,5
415 cord tissue (Wharton's jelly) chronic myeloid leukemia hematology 2017 experimental therapy Poland 5,11
416 cord tissue (Wharton's jelly) congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1,10
417 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 11,5
418 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 9,1
419 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26,10
420 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 11,11
421 cord tissue (Wharton's jelly) cerebral palsy, neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1,9
422 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,1
423 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41,0
424 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,0
425 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 21,10
426 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,4
427 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
428 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38,5
429 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,2
430 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,9
431 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42,6
432 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8,3
433 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5,2
434 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3,1
435 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,11
436 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 22,1
437 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,8
438 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,7
439 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8,6
440 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58,9
441 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8,5
442 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12,11
443 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,9
444 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42,11
445 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39,0
446 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
447 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,0
448 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,4
449 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23,7
450 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75,9
451 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25,8
452 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41,4
453 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44,2
454 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,6
455 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,9
456 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,2
457 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56,8
458 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30,0
459 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10,6
460 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24,9
461 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29,4
462 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
463 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
464 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
465 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52,9
466 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,1
467 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61,5
468 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
469 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
470 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
471 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26,11
472 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 37,7
473 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
474 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,0
475 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
476 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
477 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
478 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
479 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
480 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland no data
481 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
482 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
483 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
484 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
485 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
486 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
487 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
488 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35,5
489 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44,5
490 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
491 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
492 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
493 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
494 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
495 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
496 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
497 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
498 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
499 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
500 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,2
501 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
502 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
503 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,9
504 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,4
505 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
506 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 44,7
507 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
508 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57,6
509 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
510 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
511 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3,7
512 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16,2
513 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
514 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
515 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
516 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
517 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70,8
518 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3,6
519 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
520 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
521 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland no data
522 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
523 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
524 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
525 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
526 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
527 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
528 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,8
529 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,1
530 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41,2
531 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,4
532 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
533 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
534 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
535 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
536 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
537 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
538 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
539 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
540 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
541 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
542 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
543 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
544 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
545 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
546 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
547 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
548 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
549 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
550 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
551 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
552 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
553 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
554 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
555 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
556 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
557 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
558 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
559 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
560 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 32,3
561 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
562 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
563 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
564 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
565 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
566 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
567 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
568 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
569 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
570 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
571 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
572 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
573 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
574 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
575 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
576 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
577 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
578 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
579 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 30,3
580 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
581 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
582 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
583 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
584 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
585 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
586 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
587 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
588 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
589 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
590 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
591 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54,6
592 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86,5
593 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23,6
594 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
595 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
596 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
597 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
598 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
599 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
600 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
601 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,4
602 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,1
603 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
604 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7,4
605 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7,4
606 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13,2
607 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,6
608 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,8
609 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6,9
610 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,9
611 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
612 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,5
613 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,8
614 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
615 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
616 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
617 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
618 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
619 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
620 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
621 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
622 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
623 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
624 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
625 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
626 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
627 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
628 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
629 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
630 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
631 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
632 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
633 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
634 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
635 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
636 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
637 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
638 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
639 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
640 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
641 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
642 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
643 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
644 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
645 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
646 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
647 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
648 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
649 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
650 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
651 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,10
652 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
653 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
654 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
655 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
656 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
657 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
658 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
659 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
660 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,7
661 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,8
662 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,1
663 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,3
664 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,4
665 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,1
666 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,1
667 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,7
668 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
669 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
670 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36,1
671 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
672 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45,1
673 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
674 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
675 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
676 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
677 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
678 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
679 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
680 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
681 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
682 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
683 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
684 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
685 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
686 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
687 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
688 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
689 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
690 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
691 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
692 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
693 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
694 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
695 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
696 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
697 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
698 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
699 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
700 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
701 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
702 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
703 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
704 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
705 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
706 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
707 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
708 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
709 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
710 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
711 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
712 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
713 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
714 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
715 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
716 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
717 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
718 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
719 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
720 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
721 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
722 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
723 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
724 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
725 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
726 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
727 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
728 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
729 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
730 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
731 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
732 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
733 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
734 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
735 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
736 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
737 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
738 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
739 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
740 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
741 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
742 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
743 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
744 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
745 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
746 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
747 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
748 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
749 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
750 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
751 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
752 cord tissue (Wharton's jelly) adrenoleukodystrophy, encephalopathy neurology 2015 experimental therapy Poland 8,4
753 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
754 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
755 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
756 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
757 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
758 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
759 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
760 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
761 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
762 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
763 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
764 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
765 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
766 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
767 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
768 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
769 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
770 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
771 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
772 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
773 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
774 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
775 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
776 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
777 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
778 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
779 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
780 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
781 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
782 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
783 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
784 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
785 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
786 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
787 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
788 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
789 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
790 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
791 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
792 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
793 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
794 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
795 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
796 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
797 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
798 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
799 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
800 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
801 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
802 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
803 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
804 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
805 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
806 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
807 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
808 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
809 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
810 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
811 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
812 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
813 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
814 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
815 cord tissue (Wharton's jelly) adrenoleukodystrophy, encephalopathy neurology 2015 experimental therapy Poland 23
816 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
817 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
818 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
819 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
820 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3,3
821 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
822 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
823 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
824 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
825 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
826 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
827 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
828 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
829 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
830 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
831 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
832 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
833 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
834 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
835 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
836 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36,10
837 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
838 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
839 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
840 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
841 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
842 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
843 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
844 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
845 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
846 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
847 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
848 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
849 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
850 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
851 cord tissue (Wharton's jelly) birth asphyxia, retinopathy neurology 2014 experimental therapy Poland 11/12
852 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
853 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
854 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
855 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
856 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
857 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
858 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
859 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23,6
860 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17,5
861 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18,8
862 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3,5
863 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3,5
864 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2,11
865 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18,9
866 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4,3
867 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7,1
868 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19,7
869 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17,2
870 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Argentina 14
871 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy USA 11
872 bone marrow severe aplastic anaemia hematology 2018 standard therapy Italy 14
873 bone marrow  severe combined immunodeficiency hematology 2018 standard therapy Israel 2
874 bone marrow diffuse large B-cell lymphoma hematology 2018 standard therapy Germany 68
875 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy USA 50
876 bone marrow severe aplastic anaemia hematology 2018 standard therapy USA 19
877 bone marrow thalassemia major hematology 2018 standard therapy Sweden 14
878 bone marrow acute myelogenous leukemia hematology 2018 standard therapy Italy 36
879 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Poland 12
880 bone marrow no data hematology 2018 standard therapy Germany 16
881 bone marrow no data hematology 2018 standard therapy Spain 48
882 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Brazil 3
883 bone marrow acute myelogenous leukemia hematology 2018 standard therapy Switzerland 67
884 bone marrow acute lymphoblastic leukemia hematology 2018 standard therapy Italy 3/4
885 bone marrow bilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemia hematology 2018 standard therapy Belarus 2
886 bone marrow Hodgkin’s lymphoma hematology 2018 standard therapy USA 31
887 bone marrow juvenile myelomonocytic leukemia hematology 2018 standard therapy Hungary 11
888 bone marrow chronic granulomatous disease hematology 2018 standard therapy Switzerland 3
889 bone marrow myelodysplastic syndrome hematology 2018 standard therapy Italy 4
890 bone marrow primary Immunodeficiency, Nijmegen breakage syndrome hematology 2017 standard therapy Belarus 6
891 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 19
892 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 7
893 bone marrow Fanconi anaemia hematology 2017 standard therapy Belarus 10
894 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 8
895 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 2
896 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 18
897 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy India 7
898 bone marrow secondary acute myelogenous leukemia after Ewing sarcoma hematology 2017 standard therapy Germany 16
899 bone marrow Nijmegen breakage syndrome hematology 2017 standard therapy Poland 8
900 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Norway 2
901 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 12
902 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 2
903 bone marrow other combined immunodeficiency hematology 2017 standard therapy USA 11
904 bone marrow myeloma multiplex hematology 2017 standard therapy Canada 50
905 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 7
906 bone marrow T-cell leukemia/lymphoma hematology 2017 standard therapy Iran 18
907 bone marrow Wiskott-Aldrich syndrome hematology 2017 standard therapy Iran 2
908 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 4
909 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 14
910 bone marrow no data hematology 2017 standard therapy France 32
911 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 9
912 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 8
913 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Poland 1
914 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 24
915 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 54
916 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 56
917 bone marrow chronic myeloid leukemia hematology 2017 standard therapy USA 51
918 bone marrow acute megakaryocytic leukemia hematology 2017 standard therapy Spain 2
919 bone marrow juvenile myelomonocytic leukemia hematology 2017 standard therapy Finland 1
920 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 51
921 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 17
922 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 10
923 bone marrow Fanconi anaemia hematology 2017 standard therapy Russia 10
924 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60
925 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68
926 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10
927 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11
928 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5
929 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57
930 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59
931 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1
932 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3
933 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2
934 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2
935 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21
936 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59
937 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1
938 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9
939 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38
940 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13
941 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1
942 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16
943 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67
944 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55
945 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 6
946 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14
947 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10
948 bone marrow leukemia hematology 2017 standard therapy USA 40
949 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4
950 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30
951 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61
952 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60
953 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65
954 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
955 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
956 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
957 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
958 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
959 bone marrow anaemia hematology 2016 standard therapy Italy 5
960 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
961 bone marrow anaemia hematology 2016 standard therapy Germany 16
962 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
963 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
964 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
965 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
966 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
967 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
968 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
969 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
970 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
971 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
972 bone marrow no data n/a 2016 standard therapy Poland 33
973 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
974 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Germany 12
975 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
976 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
977 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
978 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
979 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
980 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
981 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
982 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
983 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
984 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
985 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Poland 7/12
986 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
987 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
988 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
989 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
990 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
991 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
992 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
993 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
994 bone marrow no data n/a 2016 standard therapy Poland 7
995 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
996 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
997 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
998 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
999 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
1000 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
1001 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
1002 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
1003 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
1004 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
1005 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
1006 bone marrow no data n/a 2016 standard therapy Italy 3
1007 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
1008 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
1009 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
1010 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Poland 50
1011 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 76
1012 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 46
1013 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Italy 61
1014 peripheral blood myeloma multiplex hematology 2018 standard therapy USA 57
1015 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 64
1016 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Slovenia 54
1017 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy United Kingdom 22
1018 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Poland 67
1019 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 54
1020 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 8
1021 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 62
1022 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 68
1023 peripheral blood T-cell acute lymphoblastic leukemia hematology 2018 standard therapy Poland 13
1024 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2018 standard therapy Germany 41
1025 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Italy 62
1026 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 64
1027 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 47
1028 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 50
1029 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 61
1030 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 64
1031 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 51
1032 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 61
1033 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Poland 59
1034 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 72
1035 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 54
1036 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 56
1037 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy Netherlands 67
1038 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 42
1039 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 71
1040 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 30
1041 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Italy 67
1042 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 45
1043 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 45
1044 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 61
1045 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy France 33
1046 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy France 50
1047 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 72
1048 peripheral blood myelofibrosis hematology 2018 standard therapy Germany 60
1049 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Spain 34
1050 peripheral blood Hodgkin’s lymphoma hematology 2018 standard therapy Poland 38
1051 peripheral blood acute myeloid leukemia in first complete remission hematology 2018 standard therapy Germany 61
1052 peripheral blood Secondary AML MLL(+), High risk CR1 hematology 2018 standard therapy Poland 58
1053 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy France 46
1054 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Poland 48
1055 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy Italy 65
1056 peripheral blood other myleofibrosis hematology 2018 standard therapy Poland 57
1057 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Poland 66
1058 peripheral blood non-Hodgkin lymphoma hematology 2018 standard therapy Poland 23
1059 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy United Kingdom 46
1060 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy USA 63
1061 peripheral blood myeloma multiplex hematology 2018 standard therapy Lithuania 56
1062 peripheral blood T-cell acute lymphoblastic leukemia hematology 2018 standard therapy Germany 7
1063 peripheral blood severe aplastic anaemia hematology 2018 standard therapy Germany 18
1064 peripheral blood myelodysplastic syndrome hematology 2018 standard therapy USA 74
1065 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy United Kingdom 42
1066 peripheral blood acute lymphoblastic leukemia hematology 2018 standard therapy United Kingdom 29
1067 peripheral blood myelofibrosis hematology 2018 standard therapy Netherlands 49
1068 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Canada 59
1069 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy Germany 35
1070 peripheral blood acute myelogenous leukemia hematology 2018 standard therapy USA 26
1071 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 13
1072 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 71
1073 peripheral blood no data hematology 2017 standard therapy Switzerland 68
1074 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 8
1075 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 37
1076 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 26
1077 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 10
1078 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 70
1079 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 60
1080 peripheral blood myelodysplastic syndrome in Fanconi anaemia hematology 2017 standard therapy Italy 23
1081 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 57
1082 peripheral blood Hodgkin’s lymphoma hematology 2017 standard therapy USA 25
1083 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 72
1084 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 24
1085 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
1086 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 72
1087 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 69
1088 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 57
1089 peripheral blood myeloma multiplex hematology 2017 standard therapy Poland 38
1090 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 27
1091 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 69
1092 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 40
1093 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 22
1094 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 61
1095 peripheral blood myeloma multiplex hematology 2017 standard therapy USA 57
1096 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 64
1097 peripheral blood no data hematology 2017 standard therapy Canada 55
1098 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 61
1099 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 58
1100 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 72
1101 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1102 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 71
1103 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 55
1104 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 68
1105 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 46
1106 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 26
1107 peripheral blood secondary acute myelogenous leukemia hematology 2017 standard therapy Austria 24
1108 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Russia 16
1109 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 6
1110 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 23
1111 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Israel 37
1112 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 63
1113 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 59
1114 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
1115 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1116 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
1117 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 65
1118 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
1119 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 67
1120 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 66
1121 peripheral blood no data hematology 2017 standard therapy Poland 1
1122 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 69
1123 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
1124 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 66
1125 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 52
1126 peripheral blood blastic plasmacytoid,dendritic cell neoplasm hematology 2017 standard therapy Germany 56
1127 peripheral blood myelofibrosis hematology 2017 standard therapy USA 47
1128 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1129 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 24
1130 peripheral blood primary myelofibrosis hematology 2017 standard therapy Poland 32
1131 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 71
1132 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
1133 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 21
1134 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Germany 7
1135 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
1136 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1137 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 43
1138 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 56
1139 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 51
1140 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 69
1141 peripheral blood myelofibrosis hematology 2017 standard therapy Netherlands 72
1142 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 36
1143 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Spain 28
1144 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Greece 28
1145 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 17
1146 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 16
1147 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1148 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Poland 63
1149 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Italy 61
1150 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 63
1151 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 59
1152 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1153 peripheral blood primary myelofibrosis hematology 2017 standard therapy Germany 29
1154 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 46
1155 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 62
1156 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 56
1157 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
1158 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy United Kingdom 51
1159 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 58
1160 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Netherlands 53
1161 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 40
1162 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 61
1163 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 54
1164 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Italy 57
1165 peripheral blood other malignancy hematology 2017 standard therapy France 59
1166 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 53
1167 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Germany 44
1168 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 32
1169 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 22
1170 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 53
1171 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 27
1172 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 49
1173 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
1174 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 64
1175 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 31
1176 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 57
1177 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 30
1178 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy USA 74
1179 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 52
1180 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Germany 64
1181 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 70
1182 peripheral blood no data hematology 2017 standard therapy Poland 53
1183 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 35
1184 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
1185 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
1186 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
1187 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 2
1188 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1189 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 49
1190 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 41
1191 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
1192 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 76
1193 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 68
1194 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 55
1195 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 25
1196 peripheral blood no data hematology 2017 standard therapy Poland 58
1197 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
1198 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 42
1199 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 4
1200 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 11
1201 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Amsterdam 69
1202 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 68
1203 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 43
1204 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Switzerland 67
1205 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 19
1206 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
1207 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
1208 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 58
1209 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 67
1210 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy USA 58
1211 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 65
1212 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 62
1213 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 39
1214 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 4
1215 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 63
1216 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 63
1217 peripheral blood no data hematology 2017 standard therapy Kanada 32
1218 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1219 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7
1220 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 36
1221 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 32
1222 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 38
1223 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 38
1224 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 49
1225 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
1226 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
1227 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Turkey 54
1228 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 58
1229 peripheral blood no data hematology 2017 standard therapy Russia 36
1230 peripheral blood chronic granulomatous disease hematology 2017 standard therapy Poland 4
1231 peripheral blood no data hematology 2017 standard therapy Germany 65
1232 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 29
1233 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Czech Republic 12
1234 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
1235 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29
1236 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46
1237 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35
1238 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54
1239 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23
1240 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65
1241 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38
1242 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54
1243 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39
1244 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
1245 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64
1246 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71
1247 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35
1248 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65
1249 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63
1250 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42
1251 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64
1252 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62
1253 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
1254 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53
1255 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48
1256 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4
1257 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67
1258 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67
1259 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59
1260 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62
1261 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55
1262 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59
1263 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
1264 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
1265 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
1266 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34
1267 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70
1268 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67
1269 peripheral blood T-cell acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30
1270 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
1271 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69
1272 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75
1273 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65
1274 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56
1275 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55
1276 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56
1277 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3
1278 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47
1279 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48
1280 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
1281 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56
1282 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64
1283 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33
1284 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67
1285 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53
1286 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60
1287 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
1288 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 42
1289 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75
1290 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32
1291 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54
1292 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58
1293 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57
1294 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
1295 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
1296 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23
1297 peripheral blood no data hematology 2017 standard therapy Poland 39
1298 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55
1299 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46
1300 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71
1301 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64
1302 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65
1303 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45
1304 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19
1305 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57
1306 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12
1307 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52
1308 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45
1309 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59
1310 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56
1311 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
1312 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63
1313 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61
1314 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75
1315 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66
1316 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53
1317 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46
1318 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44
1319 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66
1320 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64
1321 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20
1322 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3
1323 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47
1324 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56
1325 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
1326 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43
1327 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47
1328 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
1329 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32
1330 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57
1331 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64
1332 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75
1333 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2
1334 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54
1335 peripheral blood no data n/a 2017 standard therapy France 39
1336 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47
1337 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63
1338 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54
1339 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
1340 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56
1341 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61
1342 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63
1343 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65
1344 peripheral blood Common variable immunodeficiency, relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44
1345 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63
1346 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3
1347 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17
1348 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2
1349 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14
1350 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29
1351 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68
1352 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43
1353 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29
1354 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51
1355 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24
1356 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
1357 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
1358 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
1359 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
1360 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
1361 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
1362 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
1363 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
1364 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
1365 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
1366 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1367 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
1368 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
1369 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
1370 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
1371 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
1372 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
1373 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
1374 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
1375 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
1376 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
1377 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
1378 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
1379 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
1380 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
1381 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1382 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
1383 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59
1384 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
1385 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
1386 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
1387 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
1388 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
1389 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
1390 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1391 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
1392 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
1393 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
1394 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1395 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
1396 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
1397 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
1398 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
1399 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
1400 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
1401 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
1402 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
1403 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
1404 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
1405 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
1406 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1407 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1408 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
1409 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
1410 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
1411 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
1412 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
1413 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
1414 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
1415 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
1416 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
1417 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
1418 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
1419 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
1420 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
1421 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
1422 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
1423 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
1424 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
1425 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
1426 peripheral blood no data n/a 2016 standard therapy Poland 44
1427 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
1428 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
1429 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
1430 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
1431 peripheral blood no data n/a 2016 standard therapy Turkey 4
1432 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
1433 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
1434 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
1435 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
1436 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1437 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
1438 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 2/3
1439 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
1440 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
1441 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32
1442 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
1443 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
1444 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
1445 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1446 peripheral blood no data n/a 2016 standard therapy Poland 55
1447 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
1448 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
1449 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
1450 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
1451 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
1452 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
1453 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1454 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
1455 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1456 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
1457 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
1458 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
1459 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
1460 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
1461 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1462 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
1463 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
1464 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
1465 peripheral blood no data n/a 2016 standard therapy Netherlands 58
1466 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
1467 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
1468 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
1469 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
1470 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
1471 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
1472 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
1473 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
1474 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
1475 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
1476 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1477 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
1478 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
1479 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
1480 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
1481 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
1482 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
1483 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
1484 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
1485 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
1486 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
1487 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
1488 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
1489 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
1490 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
1491 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
1492 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
1493 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
1494 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1495 peripheral blood no data n/a 2016 standard therapy France 59
1496 peripheral blood no data n/a 2016 standard therapy Germany 17
1497 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
1498 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
1499 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
1500 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
1501 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
1502 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
1503 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
1504 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
1505 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
1506 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1507 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
1508 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
1509 peripheral blood no data n/a 2016 standard therapy Sweden 58
1510 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
1511 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
1512 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
1513 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
1514 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
1515 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
1516 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
1517 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
1518 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
1519 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
1520 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
1521 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
1522 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
1523 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
1524 peripheral blood no data n/a 2016 standard therapy Germany 71
1525 peripheral blood no data n/a 2016 standard therapy Belgium 30
1526 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
1527 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
1528 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
1529 peripheral blood no data n/a 2016 standard therapy Poland 28
1530 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
1531 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
1532 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1533 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
1534 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1535 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
1536 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
1537 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
1538 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
1539 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
1540 peripheral blood no data n/a 2016 standard therapy Netherlands 69
1541 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
1542 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
1543 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
1544 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
1545 peripheral blood no data n/a 2016 standard therapy Poland 43
1546 peripheral blood no data n/a 2016 standard therapy Netherlands 70
1547 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
1548 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
1549 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
1550 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1551 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
1552 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
1553 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}